BioCentury | Jul 21, 2014
Company News

Albany Molecular Research, Oso Biopharm deal

...Albany Molecular Research completed its acquisition of Oso Biopharm’s Oso Biopharmaceuticals Manufacturing LLC subsidiary for $110 million...
...$110 million in cash (see BioCentury, June 9). Albany Molecular Research Inc. (NASDAQ:AMRI), Albany, N.Y. Oso Biopharm Holdings LLC...
BioCentury | Jun 9, 2014
Company News

Albany Molecular Research, Oso Biopharm Holdings LLC deal

...Albany Molecular Research will acquire Oso Biopharm's Oso Biopharmaceuticals Manufacturing LLC subsidiary for $110 million in cash...
...million. AMRI had 2013 revenues of $246.6 million. Albany Molecular Research Inc. (NASDAQ:AMRI), Albany, N.Y. Oso Biopharm Holdings LLC...
Items per page:
1 - 2 of 2
BioCentury | Jul 21, 2014
Company News

Albany Molecular Research, Oso Biopharm deal

...Albany Molecular Research completed its acquisition of Oso Biopharm’s Oso Biopharmaceuticals Manufacturing LLC subsidiary for $110 million...
...$110 million in cash (see BioCentury, June 9). Albany Molecular Research Inc. (NASDAQ:AMRI), Albany, N.Y. Oso Biopharm Holdings LLC...
BioCentury | Jun 9, 2014
Company News

Albany Molecular Research, Oso Biopharm Holdings LLC deal

...Albany Molecular Research will acquire Oso Biopharm's Oso Biopharmaceuticals Manufacturing LLC subsidiary for $110 million in cash...
...million. AMRI had 2013 revenues of $246.6 million. Albany Molecular Research Inc. (NASDAQ:AMRI), Albany, N.Y. Oso Biopharm Holdings LLC...
Items per page:
1 - 2 of 2